Mo1872 - Adalimumab Persistence at 1 Year is Significantly Higher in an Integrated Health Care System than for Privately Insured Patients with Inflammatory Bowel Disease
2018
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI